In the A375, FO-1, and SK-Mel-28 melanoma cell lines treated with lamivudine, doravirine, or cabotegravir, our immunoblots revealed a concurrent partial decrease in both STING phosphorylation and PD-L1 expression levels, while total STING protein expression remained unaffected (Figure 5). Here, STING1 is linked to melanoma.